Filippo Acconcia

15PUBLICATIONS
17CO-AUTHORS
Economic models and forecastingPredictive and prognostic markersBiologically active moleculesMolecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 11, 2024
Characterization of ERα Signaling to Cell Proliferation Induced by Chronic and Pulsatile E2 Stimulation in 2D and 3D Cell Cultures.

Marco Fiocchetti, Serena Raimondi, Giovanna Bastari

|Feb 11, 2023
Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor α/Neuroglobin Pathway.

Emiliano Montalesi, Patrizio Cracco, Filippo Acconcia

|Dec 23, 2022
Mechanism Underlying Naringenin Hypocholesterolemic Effects: Involvement of Estrogen Receptor α Subtype.

Valentina Pallottini, Marco Segatto, Filippo Acconcia

|Oct 14, 2022
Evaluation of the Sensitivity of Breast Cancer Cell Lines to Cardiac Glycosides Unveils ATP1B3 as a Possible Biomarker for the Personalized Treatment of ERα Expressing Breast Cancers.

Filippo Acconcia

|Sep 23, 2022
Editorial for the Special Issue "New Drugs for Breast Cancer Treatment".

Filippo Acconcia

|Sep 03, 2022
The antiviral drug telaprevir induces cell death by reducing FOXA1 expression in estrogen receptor α (ERα)-positive breast cancer cells.

Stefania Bartoloni, Stefano Leone, Sara Pescatori

Pageof 3

Frequent Collaborators

3 joint publications

Marco Fiocchetti

3 joint publications

Maria Marino

1 joint publications

Fabrizio Bianchi

1 joint publications

Elena Maspero